188 related articles for article (PubMed ID: 21572746)
21. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
22. Treatment of symptomatic hyponatremia.
Decaux G; Soupart A
Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Hyponatremia in Patients with Acute Neurological Injury.
Human T; Cook AM; Anger B; Bledsoe K; Castle A; Deen D; Gibbs H; Lesch C; Liang N; McAllen K; Morrison C; Parker D; Rowe AS; Rhoney D; Sangha K; Santayana E; Taylor S; Tesoro E; Brophy G
Neurocrit Care; 2017 Oct; 27(2):242-248. PubMed ID: 28054290
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial.
Yang H; Yoon S; Kim EJ; Seo JW; Koo JR; Oh YK; Jo YH; Kim S; Baek SH
Kidney Res Clin Pract; 2022 May; 41(3):298-309. PubMed ID: 35286796
[TBL] [Abstract][Full Text] [Related]
25. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
[TBL] [Abstract][Full Text] [Related]
26. Hypertonic saline: patterns of and guidelines for use.
Culpepper RM; Clements BD; Pence SR
South Med J; 1994 Dec; 87(12):1203-7. PubMed ID: 7973918
[TBL] [Abstract][Full Text] [Related]
27. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.
Soupart A; Penninckx R; Crenier L; Stenuit A; Perier O; Decaux G
Kidney Int; 1994 Jan; 45(1):193-200. PubMed ID: 8127009
[TBL] [Abstract][Full Text] [Related]
28. A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia.
Vilapurathu JK; Rajarajan S
J Res Pharm Pract; 2014 Jan; 3(1):34-6. PubMed ID: 24991634
[TBL] [Abstract][Full Text] [Related]
29. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
Ward FL; Tobe SW; Naimark DMJ
Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
[TBL] [Abstract][Full Text] [Related]
30. Hyponatremia and hypernatremia: disorders of water balance.
Agrawal V; Agarwal M; Joshi SR; Ghosh AK
J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
[TBL] [Abstract][Full Text] [Related]
31. Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study.
Go S; Kim S; Son HE; Ryu JY; Yang H; Choi SR; Seo JW; Jo YH; Koo JR; Baek SH
Kidney Res Clin Pract; 2021 Sep; 40(3):371-382. PubMed ID: 34233437
[TBL] [Abstract][Full Text] [Related]
32. Hyponatremia: a problem-solving approach to clinical cases.
Assadi F
J Nephrol; 2012; 25(4):473-80. PubMed ID: 22307436
[TBL] [Abstract][Full Text] [Related]
33. A machine learning approach for predicting treatment response of hyponatremia.
Kinoshita T; Oyama S; Hagiwara D; Azuma Y; Arima H
Endocr J; 2024 Apr; 71(4):345-355. PubMed ID: 38311418
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
35. The treatment of hyponatremia.
Sterns RH; Nigwekar SU; Hix JK
Semin Nephrol; 2009 May; 29(3):282-99. PubMed ID: 19523575
[TBL] [Abstract][Full Text] [Related]
36. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
Murphy T; Dhar R; Diringer M
Neurocrit Care; 2009; 11(1):14-9. PubMed ID: 19123060
[TBL] [Abstract][Full Text] [Related]
37. Comparison between Urine Sodium and Clinical Evaluation to Assess Saline Responsiveness in Severe Hyponatremia - A Prospective Study.
N AK; Balan S; Murlidharan P; Patil S; Pisharody R
J Assoc Physicians India; 2019 Apr; 67(4):17-20. PubMed ID: 31311212
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
39. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
